CN
Ceretype Neuromedicine, Inc.
SEC filingBiotechnology · Cambridge, MA
Amount raised$400Ksold at filing
Total offering$400K
Investors in the raise3count reported to the SEC
FiledDec 18, 2025first sale Aug 6, 2024
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
David SilbersweigDirector
Emily SternExecutive Officer, Director
Richard LipkinDirector
Executive officers, directors and promoters as listed on the Form D.